Sinusitis Clinical Trial
Official title:
SinuSys Patency of Maxillary Sinus Ostia Study
Verified date | October 2014 |
Source | SinuSys Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
The purpose of this study is to assess safety and performance of the SinuSys Dilation System for dilation of the maxillary sinus ostium.
Status | Completed |
Enrollment | 36 |
Est. completion date | September 2014 |
Est. primary completion date | June 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 75 Years |
Eligibility |
Inclusion Criteria: -Diagnosis of chronic maxillary sinusitis Exclusion Criteria: - Previous antrostomy - Sinonasal tumours - Cystic fibrosis - History of facial trauma that distorts sinus anatomy and precludes access to the maxillary sinus - Pregnant or breastfeeding females - Currently participating in another drug or device study |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | St. Paul's Hospital, ENT Department | Vancouver | British Columbia |
United Kingdom | Charing Cross Hospital | London | |
United States | St. Elizabeth Medical Center | Boston | Massachusetts |
United States | Palo Alto Medical Foundation | Palo Alto | California |
United States | Valley ENT | Tucson | Arizona |
Lead Sponsor | Collaborator |
---|---|
SinuSys Corporation |
United States, Canada, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patency of Treated Area | Immediately post procedure | No | |
Secondary | Patency of Treated Area | Maxillary Sinus Ostia Patency of 33 patients analyzed. | 3 months | No |
Secondary | Number of Participants With Device-related Adverse Events as a Measure of Safety | 3 months | Yes | |
Secondary | Patency of Treated Area | Maxillary Sinus Ostia Patency of 29 patients analyzed. | 6 months | No |
Secondary | Patency of Treated Area | Maxillary Sinus Ostia of 27 patients analyzed. | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03584178 -
The Long-Term Safety of Budesonide for Patients With Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT06016335 -
MRI-based Synthetic CT Images of the Head and Neck
|
N/A | |
Active, not recruiting |
NCT02278484 -
Sinus Balloon Dilation in Pediatric Patients
|
N/A | |
Withdrawn |
NCT02071667 -
Association of Periostin Levels and Chronic Sinusitis
|
N/A | |
Completed |
NCT01420471 -
Medicated Punctured-Glove-Finger Spacer Study
|
Phase 4 | |
Completed |
NCT01118312 -
Study of Asthma and Nasal Steroids
|
Phase 4 | |
Completed |
NCT00645762 -
Balloon REmodeling Antrostomy THErapy Study
|
Phase 2 | |
Completed |
NCT01685229 -
Medical Therapy Versus Balloon Sinus Dilation for Patients With Chronic Rhinosinusitis
|
||
Active, not recruiting |
NCT03943121 -
The Effects of Steroid-eluting Stent Implant for the Treatment of Eosinophilic Chronic Rhinosinusitis With Nasal Polyps
|
N/A | |
Withdrawn |
NCT02900794 -
Gold Laser Vs. Micro-Debriders for Functional Endoscopic Sinus Surgery
|
N/A | |
Terminated |
NCT02630472 -
Topical Irrigation Therapy for CRS
|
Phase 1/Phase 2 | |
Completed |
NCT01442740 -
15-Degree Tilt, Head Up, Feet Down Body Position for Sinus Surgery Patients
|
N/A | |
Completed |
NCT01001039 -
Validation of the Facial and Cephalic Pain Inventory
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Completed |
NCT00242437 -
Hemostatic Matrix in Endoscopic Sinus Surgery
|
Phase 4 | |
Completed |
NCT00335309 -
Maxillary Sinus Irrigation in the Management of Chronic Rhinosinusitis
|
N/A | |
Completed |
NCT00236522 -
A Comparison of the Safety and Efficacy of Two Different Regimens of Levofloxacin in the Treatment of Acute Bacterial Sinusitis(Sinus Infection) in Adults.
|
Phase 3 | |
Completed |
NCT01717274 -
Hot Saline Irrigation Study
|
N/A | |
Completed |
NCT01166945 -
Short (5 Days) Versus Long (14 Days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children
|
N/A | |
Completed |
NCT00747747 -
Sinuclean's Treatment Of Sinusitis' Symptoms
|
Phase 4 |